Fny Investment Advisers, LLC Nektar Therapeutics Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 09, 2020
SELL
$14.47 - $27.96 $243,096 - $469,728
-16,800 Closed
0 $0
Q4 2019

Jan 10, 2020
BUY
$15.87 - $23.12 $20,631 - $30,056
1,300 Added 8.39%
16,800 $362,000
Q3 2019

Oct 25, 2019
BUY
$16.91 - $36.27 $262,105 - $562,185
15,500 New
15,500 $282,000

Others Institutions Holding NKTR

# of Institutions
146
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $212M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email